Doctors · investigators · 4 minutes reading

Clinical trials digest

Clinical trials for doctors: how a physician joins a study

A doctor who wants to run a clinical trial as an investigator needs a protocol, a site, GCP training, and a system that holds visits, consent, and safety events. ValidTrials is that record. We are a CRO registered with EOF. We configure the study and train the site.

DoctorsInvestigatorsGCPClinical trials
← All articles

4 min

Reading time

EU+US

Doctors and sites

1 record

Drug, device, IVD

What a doctor actually signs up for

A physician becomes an investigator when a sponsor or a CRO asks the clinic to run a protocol. The doctor is not buying software. They are taking medical responsibility for the people who join the study: eligibility, consent, visits, safety, and the judgement that a row in the record is true. GCP training is the starting point, not the whole job. Feasibility comes next — rooms, staff, competing trials, the lab, the pharmacy, and whether the schedule of activities fits the clinic’s week. We walk a site through that list before the first participant is screened. ValidTrials then holds the investigator’s participants, the forms they sign, and the queries they answer, without a second spreadsheet on a shared drive.

What a doctor actually signs up for

Full article for doctors, investigators, and readers who follow clinical trials.

GCP, feasibility, and the first site file

ICH E6(R3) describes what an investigator must be able to show: training, delegation, investigational product accountability, source data, and a trail of who changed what. A clinic that has never run a trial often has the medicine and the patients, and none of the file. The feasibility questionnaire is where that gap appears. How many eligible people sat in the waiting room last year. Who will be the study nurse. Who covers weekends. Where the product is stored. Which laboratory is used. We treat those answers as the start of the site file, not as a sales form. When the site is selected, the same facts become roles, visit windows, and accountability logs in ValidTrials.

The investigator stays the investigator

The principal investigator sees their participants and signs the forms that need a physician. Sub-investigators, study coordinators, and research nurses see the work that belongs to them. A monitor sees queries and visit reports. A sponsor sees the aggregated record the protocol allows. That split is not a preference. It is how GCP and privacy law expect a clinic to work. ValidTrials is built so a doctor does not share a login, and so a nurse does not hunt through five systems to find the consent. The medical judgement stays with the doctor. The computerized system holds the evidence of that judgement — a person, a timestamp, a reason for every change.

The investigator stays the investigator

Full article for doctors, investigators, and readers who follow clinical trials.

Drug, device, or diagnostic — the clinic is the same

A medicinal-product trial, a medical-device investigation, and an IVD performance study look different to the authority. They look similar to the clinic: a protocol, visits, consent, safety, and a product or specimen that must be accounted for. Doctors in oncology, cardiology, radiology, laboratory medicine, and surgery all join studies this way. The difference is in the clocks, the UDI or the kit lot, and the package the authority expects. We configure those differences. The investigator still runs the visit. Nothing in the system writes that a product is clinically validated. The doctor’s signature on the record is evidence. The sponsor’s conclusion is a later, named act on a locked snapshot.

How a clinic starts without a second database

The usual failure is a paper source, an Excel tracker, a separate safety mailbox, and a TMF on a portal the nurse cannot open from the ward. Queries then live in email. When the monitor arrives, the file is reconstructed. ValidTrials is the opposite of that reconstruction. Screening, consent, visits, concomitant medication, adverse events, and queries sit in one participant record. We train the coordinator on that record, not on a stack of tools. If you are a doctor considering a first study, write to mail@validtrials.com with the therapeutic area. Subscribe to the digest if you want the same language we use when a site opens, before you take the call.

How a clinic starts without a second database

Full article for doctors, investigators, and readers who follow clinical trials.

Read more from the digest.

Subscribe, or bring us the protocol.

The digest is for doctors and trial readers. The study conversation starts with us.